Nextleaf Solutions Ltd., Glacial Gold announced that Distilled CBD 100 Oil and Distilled CBD 200 Oil are available nationally through its medical cannabis distribution partner, Quebec-based Medicibis ("Mendo").Glacial GoldTM Distilled CBD 200 Oil is a first in Canada, with the high amount of CBD in a single unit (5700 mg), high potency of CBD available in an ingestible format, and best dollar value permilligram for CBD in Canada. The Company's multi-patented ingredient processing technology is the secret behind Glacial GoldTM products. Distilled CBD 200 Oil was developed to meet the needs of the everyday CBD consumer.

Glacial GoldTM CBD distilled oils are formulated with organic coconut MCT oil and a standardized doseof CBD. In British Columbia, Nextleaf is a top 10 supplier of vapes and oils. Glacial GoldTM has multiple products inside the top 20 best selling SKUs within the vape and oils categories.

CBD is increasingly thought of as a potential therapeutic treatment for opioid use disorder. On January4, 2022, the FDA approved human trials evaluating an investigational drug using CBD to be conducted at UCLA and funded by the U.S. National Institute on Drug Abuse.Medical patients including veterans, have made it clear that they need a reliable supply of consistent quality medical cannabis products for those living with PTSD, chronic pain, and other conditions that disproportionately impact veterans. According to a 2019 Veterans Health and Medical CannabisStudy, 96% of veterans reported they experience a much greater quality of life because of their cannabis consumption.

As part of the Company's commitment to improving access to medical cannabis, Nextleaf launched an assortment of accessibly priced Glacial GoldTM CBD and THC products for the medical market through Mendo. Quebec is the third-largest cannabis market in Canada, representing approximately 15% of Canadian cannabis retail sales in the country, and approximately 22% of the Canadian population. Canadian spending on medical cannabis totaled $587 million in 2020.

Medical cannabis has become an important component of Canadian healthcare, with $119 million of medical cannabis purchases reimbursed by the Federal Government through Veterans Affairs Canada in 2020.